Comparison of the efficacy of upadatinib generic drugs: analysis of differences with the original drug

Upadacitinib, as a selective Janus kinase (JAK) inhibitor, is mainly used to treat moderate to severe rheumatoid arthritis (RA) and other immune-mediated diseases. With its efficient anti-inflammatory effect and good safety, it has become an important drug in clinical treatment. As the price of the original drug is higher, a number of generic versions of upadatinib have appeared on the market, especially in some developing countries. Generic drugs produced by manufacturers such as Lucius Pharmaceuticals of Laos, Daxiong Pharmaceuticals, and Yaopin International of Bangladesh provide patients with more economical choices. The pharmaceutical ingredients of upadatinib generic drugs are basically the same as those of the original drug. They are all selective JAK inhibitors with the same active ingredients. The dosage form and specifications are as close as possible to the original drug to ensure the bioavailability and therapeutic effect of the drug.

From a pharmacological perspective, generic drugs that have been formally approved must pass strict bioequivalence tests to prove that there is no significant difference in absorption, distribution, metabolism and excretion from the original drugs. This is also the key for generic drugs to ensure similar therapeutic effects. The price of the 15mg*30 tablet upadatinib generic drug produced by Lucius in Laos is about RMB 500, which is much lower than the price of the original drug, which greatly reduces the financial burden of patients and improves the accessibility of the drug. Products from other manufacturers such as Bangladesh Yaopin International and Daxiong Pharmaceutical have also entered the market, providing patients with more choices.

Although generic drugs are highly consistent with original drugs in terms of ingredients and dosage forms, patients may still experience individual differences during use, which are related to preparation excipients, production processes and the patient's own metabolic state. Some patients report that the tolerability and effects of generic drugs are basically the same as those of the original drugs, while a small number of patients may need time to adapt or adjust the dosage under the guidance of a doctor. Therefore, when choosing generic drugs, you should ensure that they come from legitimate sources and avoid using unproven products.

Reference materials:https://www.rinvoq.com/